Institutional investors purchased a net $5.6 million shares of TXMD during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 79.15% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Generic industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CUTLER GROUP LP Bought 24.8 Thousand shares of TherapeuticsMD Inc
EQIS CAPITAL MANAGEMENT, INC. Bought 11.4 Thousand shares of TherapeuticsMD Inc
SIMPLEX TRADING LLC Bought 9.8 Thousand shares of TherapeuticsMD Inc